Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today plans to invest more than $700 million ...

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North ...

Roche's $1.25B investment in U.S. facilities boosts drug manufacturing and diabetes tech, creating thousands of jobs.

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in Holly ...

The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that ...

About a month after disclosing a $50 billion investment in its U.S. | Roche has earmarked more than $700 million to construct ...

Genentech plans to invest $700 million in a new facility in Holly Springs, North Carolina, creating 420 jobs and joining the ...

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation obesity medicines.

May 12 (Reuters) - Roche Group (ROG.S), opens new tab said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North Carolina, the latest drugmaker to ...

The new site will support Roche and its unit Genentech's future portfolio of next-generation obesity medicines.

Roche will invest $550 million in Indianapolis for a new manufacturing facility for glucose monitoring devices, adding ...

Roche and Genentech to spend $700 million building new manufacturing facility May 12, 2025 by Mai Tao Genentech , a ...